| (210) | Number of the EPO application | 17788068 |
| (220) | Filing date of the EPO application | 2017.10.12 |
| (80) | EPO patent specification publication (B) | EPB nr. 33/2020, 2020.08.12 |
| (110) | EPO patent number | 3526198 |
| (21) | Number of the application | e 2019 0923 |
| (71) | Name(s) of applicant(s), code of the country | Bristol-Myers Squibb Company, US; |
| (72) | Name(s) of inventor(s), code of the country | RICHTER Jeremy M., US;
BATES J. Alex, US; |
| (73) | Name(s) of owner(s), code of the country | BRISTOL-MYERS Squibb Company, US; |
| (54) | Title of the invention | 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 213/74 (2006.01.01); C07D 401/06 (2006.01.01); C07D 401/14 (2006.01.01); C07D 413/14 (2006.01.01); C07D 401/04 (2006.01.01); C07D 413/04 (2006.01.01); C07D 417/04 (2006.01.01); C07D 417/14 (2006.01.01); A61K 31/4427 (2006.01.01); A61P 9/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.09.30 |
| (30) | Priority | 201662408272 P, 2016.10.14, US |
| (86) | International application | PCT/US2017/056265, 2017.10.12 |
| (87) | International publication | WO 2018/071622, 2018.04.19 |